Home › Funds › LEUTHOLD GROUP, LLC › BIIB

LEUTHOLD GROUP, LLC position in BIIB

BIOGEN INC · Health Care

LEUTHOLD GROUP, LLC reported holding 34,509 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 0.73% of its reported portfolio and ranking #50 among its reported holdings. LEUTHOLD GROUP, LLC has disclosed BIIB holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)34.51K sh
Reported value held$7.79M
Portfolio Weight0.73%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LEUTHOLD GROUP, LLC's BIIB position evolved

LEUTHOLD GROUP, LLC first disclosed a stake in BIIB in Q3 2025 at 23,517 shares (US$3.3M). The position peaked in Q3 2026 at 34,509 shares, worth US$7.8M. Across 5 filings, LEUTHOLD GROUP, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 34,509 shares valued at US$7.8M — an increase of 3,020 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2025 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 23.52K $3.29M New
Q4 2025 32.59K $5.74M Add
Q1 2026 33.14K $6.08M Add
Q2 2026 31.49K $6.80M Reduce
Q3 2026 34.51K $7.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has LEUTHOLD GROUP, LLC held BIIB?

LEUTHOLD GROUP, LLC has disclosed BIIB holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is LEUTHOLD GROUP, LLC's current position in BIIB?

As of Q3 2026, LEUTHOLD GROUP, LLC holds 34.51K shares of BIIB (BIOGEN INC), valued at $7.79M, representing 0.73% of its reported portfolio and ranking #50.

Has LEUTHOLD GROUP, LLC been buying or selling BIIB?

In the latest 13F filing (Q3 2026), LEUTHOLD GROUP, LLC increased its position in BIIB. The position peaked in Q3 2026 at 34.51K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.